Video

Communicating Test Results to Patients

There are many factors involved in the process of communicating test results to patients, states John L. Marshall, MD. It is imperative for clinicians to interpret the test results and find a way to provide information that reflects the reality of the patient’s disease and the potential options that can still be pursued.

In some instances, patients will come to a visit expecting to receive test results, and the physician is caught off-guard. Practitioners should find time to understand test results, prepare accordingly before meeting with the patient, and ensure that there is a proper amount of time for the discussion, comments Marshall. This is especially important when the patient is receiving bad news.

Conversations should be tailored to the individual patient, says Marshall, as patients seek different levels of information. Some patients wish to maintain records of their test results, while other individuals simply want to know whether their disease is improving or worsening. Marshall prefers to show his patients their computed tomography scans and encourages his patients to become more knowledgeable about their disease.

Related Videos
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses current approaches and treatment challenges in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Aparna Parikh, MD
Tanios Bekaii-Saab, MD, FACP
Cindy Medina Pabon, MD, assistant professor, Sylvester Cancer Center, University of Miami; assistant lead, GI Cancer Clinical Research, Gastrointestinal Medical Oncology, University of Miami Health Systems
Aparna Parikh, MD, associate professor, medicine, Harvard Medical School; assistant in medicine, Hematology, Oncology, Massachusetts General Hospital; attending oncologist, Tucker Gosnell Center for Gastrointestinal Cancers, the Henri and Belinda Termeer Center for Targeted Therapies
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss ongoing research in gastrointestinal cancers.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss research building upon approved combinations in unresectable hepatocellular carcinoma.